Global Superficial Radiation Therapy Market By Product Type (Superficial Radiation Therapy Systems, Superficial Radiation Therapy Software), By Application (Basal Cell Carcinoma, Squamous Cell Carcinoma, Keloid Scars, Psoriasis, Kaposi Sarcoma (Plaque Stage), Bowen’s Disease, Cutaneous T-cell Lymphoma, Soft Tissue Metastases), By End-User (Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes, Dermatology Centers)), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

Superficial radiation therapy is the latest non-melanoma, non-invasive skin cancer treatment option. Surface radiation therapy performed using the SRT-100 platform. By providing a calibrated and accurate dose of radiation that penetrates only 5 millimeters below the surface of the skin, SRT-100 can safely and effectively eliminate malignant non-melanoma skin cancer cells. When talking about the precise and calibrated dose of radiation, X-rays are a form of electromagnetic radiation. These X-rays consist of light or photons particles. SRT-100 uses these controlled amounts of electromagnetic energy or radiation to impact non-melanoma skin cancer cells to disrupt and prevent the mitotic process. Cancer occurs when the mitotic process gets out of control and spreads malignant cells throughout the body.

In some cases, abnormal cell growth is so severe that the tumor is formed. When cancer has spread throughout the body, this is called metastasis. The precise and calibrated doses of surface radiation therapy mentioned above damage the DNA of cancer cells, thereby preventing them from growing, dividing, and ultimately dying. Despite the significance of radiation therapy, medical scientists continue to weigh their effectiveness against invasive treatments. Also, the high costs related to the use of superficial radiation therapy systems are a matter of discussion in the medical community. So, market vendors are required to design a fantastic business strategy to break over the barriers to the growth of the market.

The effectiveness and safety of superficial radiation therapy systems for the treatment of malignant non-melanoma skin cancer will continue to help the market grow. Globally, the rising prevalence of skin cancer mainly driven by market growth. Superficial radiation therapy can effectively have treated with minimal postoperative complications that promote market growth, changing lifestyles and increasing demand for non-invasive surgery, further improved market demand. As a result, ongoing R & D and major participants expected to increase capacity will create potential demand beyond expectations period. Nearly about five million cases diagnosed every year, according to recent studies.

The widespread occurrence further accelerated the cancer treatment options pipeline and related investments. Increasing preference for non-invasive procedures is a significant factor behind the change to superficial radiation. The integration of AI in shallow radiation therapy has a profound impact on many areas, some of which are treatment planning, automated imaging, and clinical decision support.

The increasing demand for personalized radiation therapy will also promote the penetration of AI in shallow radiation therapy systems. AI can use historical data to personalize the dose of independent patients. Non-invasive procedures for the management and treatment of non-melanoma skin cancers present enormous opportunities for the growth of the global market. Market providers in the Superficial radiation therapy market are looking for new opportunities. North America expected to be the leading region in the superficial radiotherapy system market. The region’s prominence is the result of a growing pipeline of cancer treatments that require low doses of red blood cells. Also, technological advancement that is focusing on the energy efficiency of superficial radiation systems is a crucial factor driving the growth of the North America superficial radiotherapy system market.

Segmentation:

By Product Type:

• Superficial Radiation Therapy Systems
• Superficial Radiation Therapy Software

By Application:

• Basal Cell Carcinoma
• Squamous Cell Carcinoma
• Keloid Scars
• Psoriasis
• Kaposi Sarcoma (Plaque Stage)
• Bowen’s Disease
• Cutaneous T-cell Lymphoma
• Soft Tissue Metastases

By End-User:

• Hospitals
• Ambulatory Surgical Centers
• Cancer Research Institutes
• Dermatology Centers

By Country:

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

Key Players:

• Xstrahl Limited
• Sensus Healthcare